A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...
News
- 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years
- Dean Kamen-founded ARMI to complete biomanufacturing center by 2027 - Boston Business Journal
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech says therapy helps patients keep weight off post-GLP-1.
- BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
... San Antonio Breast Cancer Symposium taking place December 9-12, 2025 at ... When it comes to biotech ETFs, they give sector participants exposure to ...
- CellRight Technologies, LLC Announces Update and Senior Leadership Changes
CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives. SAN ANTONIO, TX / ACCESS ...
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
Ralph DeFronzo, Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio. ... biotech and finance leaders seeking clear, ...